Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares OutstandingShares Outstanding
Ratios

United Health Products (UEEC) Long-Term Debt Issuances (2016 - 2025)

United Health Products' Long-Term Debt Issuances history spans 11 years, with the latest figure at -$275000.0 for Q4 2025.

  • Quarterly results put Long-Term Debt Issuances at -$275000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $145000.0 (changed N/A YoY), and the annual figure for FY2025 was $145000.0, changed.
  • Long-Term Debt Issuances for Q4 2025 was -$275000.0 at United Health Products, down from $400000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $400000.0 in Q3 2025 to a low of -$275000.0 in Q4 2025.
  • The 3-year median for Long-Term Debt Issuances is $55000.0 (2021), against an average of $58347.5.
  • Peak annual rise in Long-Term Debt Issuances hit 825.0% in 2022, while the deepest fall reached 185.91% in 2022.
  • Year by year, Long-Term Debt Issuances stood at $221500.0 in 2021, then tumbled by 185.91% to -$190300.0 in 2022, then tumbled by 44.51% to -$275000.0 in 2025.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods came in at -$275000.0, $400000.0, and -$70000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.